Vascepa is a prescription medication used to treat high levels of triglycerides in the blood. It contains the active ingredient icosapent ethyl, which is a type of omega-3 fatty acid. According to the Drug Patent Watch website [1], there are no dosage recommendations for Vascepa when taken with blood thinners. However, it is important to note that Vascepa can increase the risk of bleeding when taken with other medications that affect blood clotting, such as aspirin or warfarin. Therefore, it is essential to consult a healthcare provider before taking Vascepa with blood thinners.
According to Medical News Today [2], the usual recommended dose of Vascepa is 4 grams per day, taken as two capsules twice daily with food. However, the dosage may vary depending on the patient's medical condition, age, and other factors. The healthcare provider will determine the appropriate dosage based on the patient's individual needs.
The FDA-approved label for Vascepa [3] provides detailed information on the recommended dosage and administration of the medication. According to the label, the recommended dose of Vascepa is 4 grams per day, taken as two capsules twice daily with food. The label also states that Vascepa should be used with caution in patients taking anticoagulants or other medications that affect blood clotting, as it may increase the risk of bleeding.
In conclusion, there are no specific dosage recommendations for Vascepa when taken with blood thinners, according to the Drug Patent Watch website [1]. However, it is important to consult a healthcare provider before taking Vascepa with blood thinners, as it may increase the risk of bleeding. The usual recommended dose of Vascepa is 4 grams per day, taken as two capsules twice daily with food, according to Medical News Today [2] and the FDA-approved label [3]. The healthcare provider will determine the appropriate dosage based on the patient's individual needs and medical condition.
Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.medicalnewstoday.com/articles/drugs-vascepa
[3] https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202057s035lbl.pdf